IRBM

IRBM is a scientific contract research organization (CRO) that stands at the forefront of drug discovery, leveraging a single, unified research facility to accelerate team-based breakthroughs and improve efficiencies from concept to candidate. With a history of contributing to four approved drugs, and its own internal pipeline of oncology and other therapeutic assets, IRBM is powered by deep collaborations and decades of expertise from leading global institutions. Their comprehensive in-house capabilities assist partners in achieving key milestones and progressing towards clinical readiness, positioning IRBM as a major player in driving innovation in the pharmaceutical and biotech fields. Find more detailed...

Drug discovery,dmpk,peptide chemistry,medicinal chemistry,assay development,high-throughput screening,preclinical research,pharmacology,biochemistry,nmr,infectious diseases,neurodegeneration,and oncology

Irbm operates in the Biotechnology research industry.

Irbm's revenue is 11m - 100m

Irbm has 201 - 500 employees.